This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Pembrolizumab
KEYTRUDA – MERCK CANADA INC (NOC Search)
Patents:
- 2691357:
- 2830806:
Unknown/Other
- PM(NOC) – A-143-21 (2021 FCA 224) – T-1476-20 (2021 FC 345)
Return to the Patented Medicine Litigation page.